Eric Schmidt

Stock Analyst at Cantor Fitzgerald

(0.54)
# 2639
Out of 5,441 analysts
54
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
SRRK Scholar Rock Holding
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Jul 17, 2025
RNA Avidity Biosciences
Reiterates: Overweight
96 96
45.74 109.88% 5 Jun 27, 2025
PRTA Prothena Corp
Reiterates: Neutral
n/a
n/a n/a 2 Jun 20, 2025
CDTX Cidara Therapeutics
Reiterates: Overweight
n/a
n/a n/a 2 Jun 10, 2025
SMMT Summit Therapeutics
Reiterates: Overweight
n/a
n/a n/a 2 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 4 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 4 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
14 14
9.95 30.75% 2 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 4 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 6 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 4 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 3 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 2 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
292 292
128.03 128.07% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
370
374.47 -1.19% 1 Oct 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Jul 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
31
7.16 332.96% 1 Jun 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 May 30, 2017